Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Sees Significant Drop in Short Interest

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 64,700 shares, a drop of 28.0% from the February 28th total of 89,800 shares. Based on an average trading volume of 87,000 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.1% of the company’s stock are short sold.

Xtant Medical Price Performance

NYSEAMERICAN XTNT traded down $0.01 on Friday, hitting $0.49. The stock had a trading volume of 12,094 shares, compared to its average volume of 103,456. The business has a fifty day moving average of $0.54. The company has a market capitalization of $68.03 million, a PE ratio of -3.76 and a beta of 0.35. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.88 and a current ratio of 2.12. Xtant Medical has a 52-week low of $0.33 and a 52-week high of $1.18.

Hedge Funds Weigh In On Xtant Medical

An institutional investor recently raised its position in Xtant Medical stock. Geode Capital Management LLC raised its position in shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) by 70.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 515,006 shares of the medical device company’s stock after purchasing an additional 212,394 shares during the quarter. Geode Capital Management LLC owned 0.37% of Xtant Medical worth $348,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 69.33% of the company’s stock.

Xtant Medical Company Profile

Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.